Breast cancer happens when cells in the breast start dividing abnormally and keep growing without stopping. It’s the most diagnosed cancer in Indian women and something has shifted — younger women in their 30s are now walking in with diagnoses that used to be rare at that age. Finding it early genuinely changes what treatment can offer.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India,
“We still see women coming in at a stage that could have been caught months earlier  that delay costs them options they simply can’t get back.”

The signs aren’t always what people expect and some of the most important risk factors get dismissed until it’s too late.

• What to Watch For: A new lump in the breast or armpit, skin that dimples or puckers, nipple discharge or breast pain that doesn’t follow the normal monthly cycle — none of these should be watched at home for weeks before getting assessed.
• Hormonal History: Women who started periods early, went through menopause late or used hormone therapy long-term carry higher cumulative oestrogen exposure, and breast cancer treatment discussions in these cases often begin well before any diagnosis is confirmed.
• BRCA Mutations: Carrying a BRCA1 or BRCA2 mutation significantly raises lifetime risk, and women with a strong family history of breast or ovarian cancer should talk to a specialist about testing before any symptoms show up.
• Lifestyle Patterns: Post-menopausal weight gain, regular alcohol use and low physical activity are all independently linked to higher breast cancer incidence — patterns that have shifted considerably across urban India in the past fifteen years.

These factors don’t guarantee cancer will develop but they shape how early and how often screening needs to happen.

Getting to a confirmed diagnosis takes a structured sequence of steps and each one builds on the last.

• Examination First: A specialist physically checks for lump characteristics, skin changes and axillary lymph node enlargement — this hands-on assessment is what determines what imaging gets ordered and how quickly.
• Imaging: Mammography works well for women above 40 while ultrasound suits younger women with denser tissue better, and MRI gets added when the surgical team needs precise tumour mapping before deciding on an operative approach.
• Biopsy Confirms: A core needle biopsy is what actually tells the team whether cancer is present, what type and grade it is, and whether it’s hormone receptor positive or HER2 positive — results that determine the whole treatment plan.
• Staging Scans: Once cancer is confirmed, CT and bone scan check for spread beyond the breast, with PET-CT used in locally advanced cases where the team needs the full disease picture before sequencing treatment.

Working through all of this at a centre where pathology, imaging and surgery genuinely operate together matters more than most patients realise, and for more on surgical options after diagnosis, our blog on breast reconstruction covers post-surgical care in detail.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to every breast cancer case. He heads Oncology Services across Karnataka and leads breast cancer surgery at KIMS Hospital, Bangalore, with originator credits for RABIT and over 25 published studies. Patients seeking diagnosis, a second opinion or a clear surgical plan are seen here with tumour board input on every decision. Call +91 8104310753 to book your consultation.

References

1. 1. National Cancer Institute — Breast Cancer Diagnosis
   2. World Health Organization — Breast Cancer Overview

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

HIPEC stands for Hyperthermic Intraperitoneal Chemotherapy. Right after cytoreductive surgery removes all visible tumour, heated chemotherapy is circulated directly inside the abdominal cavity. The heat makes the drugs more effective and the direct delivery reaches microscopic cancer cells that surgery couldn’t physically remove and that IV chemotherapy struggles to reach at useful concentrations.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India,
“HIPEC puts chemotherapy exactly where the disease is, at a concentration systemic treatment through the bloodstream simply cannot match at that specific site.”

HIPEC always follows cytoreductive surgery in the same operating session and the two together are what produce the outcome neither achieves alone.

• Surgery Comes First: All visible tumour is removed from peritoneal surfaces before HIPEC begins. Delivering heated chemotherapy into a cavity that still has significant disease doesn’t produce the result the procedure is designed for.
• Heated Drug Circulation: Chemotherapy solution at 41 to 43 degrees Celsius circulates through the cavity for 60 to 90 minutes. Heat increases how deeply the drug penetrates remaining tissue beyond what room-temperature delivery achieves.
• Higher Local Concentration: Drug levels inside the peritoneal cavity during HIPEC treatment are far higher than anything IV chemotherapy produces at that site, which matters because peritoneal deposits are poorly reached through the bloodstream.
• Closed Technique: The abdomen is sealed before circulation starts with drugs delivered through tubes placed during surgery. This protects theatre staff and keeps temperature consistent throughout the full treatment cycle.

The combined procedure from cytoreduction through to HIPEC completion typically runs eight to twelve hours in total.

HIPEC has the strongest evidence in cancers that spread to the peritoneal lining rather than to distant organs through the bloodstream.

• Ovarian Cancer: HIPEC after cytoreduction has shown clear survival benefit in advanced ovarian cancer, particularly where neoadjuvant chemotherapy has already reduced disease to a point that allows complete or near-complete removal.
• Colorectal Peritoneal Metastasis: This is the most common HIPEC indication in India. Robotic cancer surgery or open cytoreduction removes visible deposits before heated oxaliplatin or mitomycin addresses what’s left behind microscopically.
• Pseudomyxoma Peritonei: This slow-growing appendix-origin tumour responds particularly well to cytoreduction and HIPEC, with long-term control achievable in selected patients when complete cytoreduction is reached.
• Gastric and Mesothelioma: Selected gastric cancer patients with limited peritoneal involvement and peritoneal mesothelioma cases are considered when disease extent and fitness make the combined procedure a reasonable option.

Not every centre has the volume or setup to offer HIPEC safely, and for a clearer picture of the surgery that makes it possible, cancer surgery is covered separately.

Dr. Sandeep Nayak holds DNB qualifications in Surgical Oncology and General Surgery with a fellowship in Laparoscopic and Robotic Onco-Surgery and 24 years performing cytoreductive surgery and HIPEC across ovarian, colorectal, gastric and peritoneal cancers. He leads surgical oncology at KIMS Hospital, Bangalore and heads Oncology Services across Karnataka, with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published studies. Patients referred for HIPEC or declined elsewhere are assessed here through full tumour board review before any decision is made. Call +91 8104310753 to book your consultation.

References

1. 1. National Cancer Institute — Surgery to Treat Cancer
   2. National Institutes of Health — HIPEC and Peritoneal Cancer Treatment

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

Robotic surgery is a minimally invasive technique where surgeons use computer-controlled robotic arms to perform precise operations through small incisions. In cancer treatment, it enhances dexterity and provides 3D, high-definition visualization for better tumor removal, resulting in less pain, reduced blood loss, and faster recovery compared to traditional open surgery.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India, “robotic surgery changes what is technically achievable in certain anatomical locations  particularly the pelvis, chest and around the base of the skull where standard instruments have real limitations.”

The system has three main components and each one plays a specific role in how the procedure is performed.

• Surgeon Console: The operating surgeon controls robotic arms from here using hand and foot movements, viewing a three-dimensional magnified image of the operative field while every instrument motion gets translated with far greater precision than manual laparoscopy allows.
• Patient Cart: This robotic unit sits beside the table holding three or four arms that pass instruments and a camera through small incisions, with a range of movement at the instrument tip that exceeds what a human wrist can physically achieve inside a confined surgical space.
• Tremor Filtration: The system filters natural hand tremor and scales movements so a larger motion at the console becomes a smaller more precise action inside the patient, which is particularly valuable when dissecting close to robotic cancer surgery sites involving major vessels or delicate nerves.
• Oncological Standards: Margins still need to be clear, lymph nodes still get assessed and the procedure is held to exactly the same oncological standards as open or laparoscopic surgery because the platform extends what the surgeon can do, not what the surgery needs to achieve.

The robotic system assists the surgeon clinical judgment behind every decision still belongs entirely to the person at the console.

Certain anatomical sites benefit from robotic assistance more than others and those are where the technology has become most established in cancer care.

• Prostate Cancer: Robotic radical prostatectomy is one of the most performed robotic cancer operations globally, with the three-dimensional view allowing surgeons to work close to neurovascular bundles controlling continence and sexual function with considerably less risk of damaging them.
• Rectal Cancer: Deep pelvic dissection for rectal cancer is where robotic surgery arguably makes its biggest difference, allowing total mesorectal excision in a narrow pelvis where laparoscopic cancer surgery can be technically difficult to complete to the required oncological standard.
• Gynaecological Cancers: Robotic radical hysterectomy and lymph node dissection for cervical and uterine cancers are now standard at high-volume centres, with robotic dexterity well suited to pelvic anatomy where precision directly affects post-operative function.
• Head, Neck and Thyroid: Transoral robotic surgery reaches the base of tongue and oropharyngeal tumours without any external incision, and robotic thyroidectomy through the axilla leaves no visible scar on the neck at all outcomes open surgery simply cannot offer for these specific sites.

Patient selection and surgeon experience determine whether robotic surgery is appropriate for any given case, and for broader context on how surgical approaches are selected, cancer surgery is covered separately.

Dr. Sandeep Nayak holds DNB qualifications in Surgical Oncology and General Surgery with a fellowship in Laparoscopic and Robotic Onco-Surgery and 24 years of experience performing robotic cancer operations across prostate, colorectal, gynaecological, head and neck and thyroid cancers. He leads Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore and heads Oncology Services across Karnataka, with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies. Patients who want an honest assessment of whether robotic surgery is genuinely appropriate for their case are seen here with every decision going through tumour board review first. Call +91 8104310753 to book your consultation.

Reference links:

1. National Cancer Institute — Surgery to Treat Cancer
2. National Institutes of Health — Robotic Surgery in Oncology

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

Laparoscopic cancer surgery is a minimally invasive technique using 3–5 tiny incisions, a high-magnification camera (laparoscope), and specialized instruments to remove tumours with high precision. This approach offers faster recovery, less pain, reduced blood loss, and fewer infections compared to open surgery. It is commonly used for colorectal, gynecological, kidney, and prostate cancers. 

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India, “the smaller incisions aren’t the point what matters is achieving the same oncological result while reducing how much the operation itself sets the patient back physically.”

The mechanics differ from open surgery but the standards for margin clearance and lymph node removal stay exactly the same throughout.

• Creating Access: Small incisions allow the camera and instruments in, carbon dioxide inflates the cavity to create a working room, and the surgeon operates from outside the body while watching a magnified view on screen that often shows anatomy more clearly than direct vision through a large incision would.
• The Resection: Cancer is dissected free of surrounding tissue, lymph nodes are taken where needed and the specimen comes out through one of the incisions, sometimes with a small extension to the opening margin requirements don’t change just because the approach is minimally invasive.
• Recovery Difference: Most patients are walking the next day and go home within two to four days, which matters clinically because patients who recover faster from surgery tolerate adjuvant chemotherapy better and start it sooner.
• When It’s Not Used: Tumours that have grown into major vessels, certain very large lesions or cases where previous abdominal surgery has created significant scarring may not be suitable, and laparoscopic cancer surgery is only offered when the surgeon is confident the oncological result won’t be compromised by the approach.

Patient selection is what makes laparoscopic cancer surgery safe and effective, and getting that selection wrong is what creates problems.

The range has expanded considerably over the past decade and laparoscopic approaches are now standard for several cancer types that previously required open surgery as a default.

• Colorectal Cancer: Laparoscopic colectomy and rectal resection are probably the most established minimally invasive cancer operations available, with long-term data showing the same survival, recurrence and margin outcomes as open surgery when the surgeon has sufficient volume and experience.
• Gastric Cancer: Stomach cancer surgery laparoscopically is increasingly common particularly in early and locally advanced cases, though D2 lymphadenectomy demands a high level of operative skill and isn’t something every centre should be attempting through this approach.
• Gynaecological Cancers: Radical hysterectomy, lymph node dissection and staging procedures for uterine and cervical cancers are routinely done laparoscopically, and in some pelvic cases robotic cancer surgery offers additional precision that the standard laparoscopic setup doesn’t quite match.
• Liver and Adrenal: Left lateral liver resections and adrenalectomies that once required large incisions are now regularly completed laparoscopically at high-volume centres, though right-sided liver resections and anything involving major vascular reconstruction still sit outside what most laparoscopic programmes should routinely take on.

The decision about whether laparoscopy works for a specific case depends entirely on the tumour and the team, and for context on how this fits into the broader picture of cancer surgery decisions, cancer surgery is covered separately.

Dr. Sandeep Nayak trained specifically in laparoscopic cancer surgery through a dedicated fellowship in Laparoscopic and Robotic Onco-Surgery and holds DNB qualifications in Surgical Oncology and General Surgery, with 24 years of minimally invasive oncological experience across colon, gastric, gynaecological, liver and other cancer types. He heads Oncology Services across Karnataka and leads Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore, with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies. Patients who want an honest assessment of whether a laparoscopic approach is genuinely possible for their case are seen here with every decision reviewed through tumour board consensus first. Call +91 8104310753 to book your consultation.

Reference links:

1. National Cancer Institute — Surgery to Treat Cancer
2. National Institutes of Health — Minimally Invasive Surgery in Oncology

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

Cancer staging classifies the size, location, and spread of cancer (Stages 0-IV) using the TNM system Tumor size, Node involvement, and Metastasis. This process is critical because it dictates whether surgery is appropriate for curative, palliative, or diagnostic purposes, determining if a tumor can be resected (removed) or if systemic treatment is needed first

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India, “staging isn’t just a number we assign, it’s a clinical picture that tells us whether the disease is still within reach surgically and what we can realistically offer the patient at that point.”

Staging combines imaging, biopsy results and sometimes surgical findings to build the most accurate picture possible of how far the disease has progressed.

• Imaging Assessment: CT scans, MRI and PET scans map the tumour’s size, location and whether it has reached nearby structures or distant organs, giving the surgical team a baseline before any decision about operating is made.
• Pathological Staging: Once a biopsy confirms the cancer type and grade, that information combines with imaging to produce a clinical stage, and in some cases the final stage can only be confirmed after surgery when lymph nodes and surrounding tissue are examined properly.
• TNM Classification: Most solid tumour cancers are staged using a system that scores tumour size, node involvement and distant spread separately, and it’s the combination of those three scores rather than any single factor that determines the overall stage and what laparoscopic cancer surgery or other approaches can realistically achieve.
• Staging Surgery: When scans aren’t enough to confirm spread, a surgical staging procedure physically examines the peritoneum, lymph nodes or surrounding structures to fill in the gaps that imaging simply cannot resolve with enough certainty to plan treatment around.

Staging isn’t a one-time event for every cancer type  some cancers get restaged after initial treatment to see whether the disease has responded well enough to change what’s surgically possible next.

The stage isn’t just background information. It’s the primary variable that shapes what the surgical team can offer and in what order.

• Early Stage Cancers: When disease is confined to the primary site and hasn’t reached lymph nodes or distant organs, surgery with clear margins is usually the first and most important step because the realistic chance of removing the problem entirely is at its highest.
• Locally Advanced Disease: A tumour that has grown into surrounding structures or involved regional lymph nodes may not be safely resectable straight away, which is why chemotherapy or radiation often runs first to shrink it before robotic cancer surgery becomes technically possible with acceptable margins.
• Borderline Resectable Cases: Some tumours sit right on the edge of what’s operable, close to a major vessel or involving a critical structure, and the staging findings are what the tumour board uses to decide whether surgery should be attempted or whether a non-operative approach gives the patient a better outcome.
• Stage 4 Disease: Distant spread doesn’t automatically rule out surgery but it fundamentally changes its intent curative resection is rarely on the table but palliative surgery to relieve obstruction, control bleeding or reduce tumour burden can still make a meaningful difference to the patient’s quality of life.

Staging and surgical planning are inseparable, and for a clearer account of how different cancer surgeries are approached once staging is confirmed, cancer surgery is covered separately.

Dr. Sandeep Nayak holds DNB qualifications in Surgical Oncology and General Surgery with a fellowship in Laparoscopic and Robotic Onco-Surgery and 24 years of experience translating staging findings into surgical decisions across a wide range of cancer types and presentations. He leads cancer surgery and Robotic Surgery at KIMS Hospital, Bangalore and heads Oncology Services across Karnataka, with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies. Patients with complex staging findings, borderline resectable tumours or cases that other centres have found difficult to categorise are assessed here with every operative decision going through full tumour board review. Call +91 8104310753 to book your consultation.

Reference links:

1. National Cancer Institute — Cancer Staging
2. National Institutes of Health — TNM Classification and Surgical Planning

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.